SS
KYNB

Steve Schonfeld’s Kyntra Bio KYNB Stock Holding History

Steve Schonfeld’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,968
Closed -$43.9K – 2158
2024
Q2 		$43.9K Buy
1,968
+388
+25% +$12K ﹤0.01% 1947
2024
Q1 		$92.8K Buy
+1,580
New +$68.1K ﹤0.01% 1857
2023
Q3 		– Sell
-2,209
Closed -$149K – 1926
2023
Q2 		$149K Buy
+2,209
New +$914K ﹤0.01% 1643
2022
Q4 		– Sell
-1,983
Closed -$645K – 2722
2022
Q3 		$645K Buy
+1,983
New +$639K 0.01% 1571
2021
Q2 		– Sell
-1,592
Closed -$1.38M – 2051
2021
Q1 		$1.38M Buy
+1,592
New +$1.7M 0.02% 780
2019
Q1 		– Sell
-2,852
Closed -$3.3M – 1092
2018
Q4 		$3.3M Buy
+2,852
New +$3.21M 0.13% 225
2016
Q3 		– Sell
-1,609
Closed -$660K – 457
2016
Q2 		$660K Buy
+1,609
New +$737K 0.15% 189

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Steve Schonfeld's KYNB Position: Q3 2024 in Review

Steve Schonfeld sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 1,968 shares — an estimated $43.9K sold.

Steve Schonfeld first reported a position in KYNB in Q2 2016 and held it in 7 quarters. The position peaked at $3.3M in Q4 2018. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Steve Schonfeld reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Steve Schonfeld sold 1,968 Kyntra Bio shares in Q3 2024, an estimated $43.9K.
  • Steve Schonfeld first reported a position in Kyntra Bio in Q2 2016 and held it in 7 quarters.
  • Steve Schonfeld's Kyntra Bio position peaked at $3.3M in Q4 2018.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.